Growth Metrics

Cellectis (CLLS) EPS (Weighted Average and Diluted): 2013-2022

Historic EPS (Weighted Average and Diluted) for Cellectis (CLLS) over the last 9 years, with Dec 2022 value amounting to -$2.33.

  • Cellectis' EPS (Weighted Average and Diluted) fell 83.04% to -$0.73 in Q3 2017 from the same period last year, while for Sep 2017 it was -$1.23, marking a year-over-year decrease of 7.50%. This contributed to the annual value of -$2.33 for FY2022, which is 8.63% up from last year.
  • Latest data reveals that Cellectis reported EPS (Weighted Average and Diluted) of -$2.33 as of FY2022, which was up 8.63% from -$2.55 recorded in FY2021.
  • In the past 5 years, Cellectis' EPS (Weighted Average and Diluted) ranged from a high of -$1.91 in FY2020 and a low of -$2.55 during FY2021.
  • For the 3-year period, Cellectis' EPS (Weighted Average and Diluted) averaged around -$2.26, with its median value being -$2.33 (2022).
  • In the last 5 years, Cellectis' EPS (Weighted Average and Diluted) surged by 30.58% in 2018 and then crashed by 33.51% in 2021.
  • Over the past 4 years, Cellectis' EPS (Weighted Average and Diluted) (Yearly) stood at -$1.93 in 2018, then reached -$1.91 in 2020, then tumbled by 33.51% to -$2.55 in 2021, then increased by 8.63% to -$2.33 in 2022.